Umeclidinium Bromide Powder
NDC Package 63379-113-00
Package Information
Umeclidinium Bromide powders is umeclidinium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). This formulation utilizes a powder delivery system. Marketed by Glaxo Operations Uk Ltd, this product is identified by NDC 63379-113.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63379 - Glaxo Operations Uk Ltd
- 63379-113 -
- 63379-113-00 - 11 kg in 1 DRUM
- 63379-113 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63379-113-00 identifies a specific commercial package of 11 kg in 1 drum of Umeclidinium Bromide (UNFINISHED drug), a bulk ingredient labeled by Glaxo Operations Uk Ltd. This powder is formulated for use and contains umeclidinium bromide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Glaxo Operations Uk Ltd on January 01, 2024. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Umeclidinium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes bronchitis and emphysema). It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Umeclidinium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed.
How is this Glaxo Operations Uk Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63379011300. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.